QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Leadership Team with Appointment of Accomplished Life Science Executives
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Catherine M. Vaczy as executive vice president and chief strategy officer and Michael T. Redman as executive vice president and chief operating officer. These appointments follow on the heels of Genprex’s Fast … Continue reading “QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Leadership Team with Appointment of Accomplished Life Science Executives”